These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 11605121)

  • 1. [RC-Cornet(R) improves the bronchodilating effect of Ipratropiumbromide (Atrovent(R)) inhalation in COPD-patients].
    Cegla UH; Jost JH; Harten A; Weber T
    Pneumologie; 2001 Oct; 55(10):465-9. PubMed ID: 11605121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Course of Severe COPD with and without Physiotherapy with the RC-Cornet(R)].
    Cegla UH; Jost HJ; Harten A; Weber T; Wissmann S
    Pneumologie; 2002 Jul; 56(7):418-24. PubMed ID: 12140795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of an oscillating physiotherapy device (RC-Cornet trade mark) on the regional distribution of the pulmonary aerosol deposition in patients with COPD].
    Haidl P; Rickert G; Cegla UH; Köhler D
    Pneumologie; 2002 Aug; 56(8):498-502. PubMed ID: 12174335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of domiciliary nebulizers in managing patients with severe COPD.
    Eiser N; Angus K; McHale S
    Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Response to inhaled bronchodilators in chronic airway obstruction].
    Holten K
    Tidsskr Nor Laegeforen; 1993 Feb; 113(4):444-7. PubMed ID: 8465284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of salbutamol and ipratropium bromide on arterial blood gases in patients with stable COPD].
    Ozdemir T; Geçkin E; Oğüş C; Cilli A
    Tuberk Toraks; 2003; 51(2):132-7. PubMed ID: 15143418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of salbutamol aerosol therapy via metered dose inhaler-spacer vs. jet nebulizer in young children with wheezing.
    Deerojanawong J; Manuyakorn W; Prapphal N; Harnruthakorn C; Sritippayawan S; Samransamruajkit R
    Pediatr Pulmonol; 2005 May; 39(5):466-72. PubMed ID: 15786440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, comparative trial of standard and breath-actuated nebulizer: efficacy, safety, and satisfaction.
    Arunthari V; Bruinsma RS; Lee AS; Johnson MM
    Respir Care; 2012 Aug; 57(8):1242-7. PubMed ID: 22348319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life measurements and bronchodilator responsiveness in prescribing nebulizer therapy in COPD.
    Brophy C; Kastelik J; Gardiner E; Greenstone M
    Chron Respir Dis; 2008; 5(1):13-8. PubMed ID: 18303097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM; Phillips C; Wooler PA
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equivalence of pharmacokinetic characteristics and bronchodilating effect between two combined formulations of nedocromil sodium and salbutamol: MDI and nebulizer solution.
    Reggio S; Bustacchini S; Pistelli R; Valente S
    Int J Clin Pharmacol Res; 1996; 16(1):19-27. PubMed ID: 9001926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchodilator therapy with metered-dose inhaler and spacer versus nebulizer in mechanically ventilated patients: comparison of magnitude and duration of response.
    Duarte AG; Momii K; Bidani A
    Respir Care; 2000 Jul; 45(7):817-23. PubMed ID: 10926377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the bronchodilating efficacies of a novel salbutamol metered dose powder inhaler and a pressurised metered dose aerosol with a spacer.
    Seppälä OP; Kari E; Elo J; Löyttyniemi E; Kunkel G
    Arzneimittelforschung; 1998 Sep; 48(9):919-23. PubMed ID: 9793619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of bronchodilators and oxygen alone and in combination on self-paced exercise performance in stable COPD.
    Cukier A; Ferreira CA; Stelmach R; Ribeiro M; Cortopassi F; Calverley PM
    Respir Med; 2007 Apr; 101(4):746-53. PubMed ID: 17000096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing COPD treatment: nebulizer, metered dose inhaler, and concomitant therapy.
    Tashkin DP; Klein GL; Colman SS; Zayed H; Schonfeld WH
    Am J Med; 2007 May; 120(5):435-41. PubMed ID: 17466655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A comparison of two delivery methods on the bronchodilator effects of beta 2-stimulant].
    Kishida M; Suzuki I; Koshibu T; Matsumoto H; Uchiyama Y; Kabayama H; Nagayama T; Sasamoto A; Aoki T
    Arerugi; 1996 Jun; 45(6):542-5. PubMed ID: 8776948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dry powder ipratropium bromide is as safe and effective as metered-dose inhaler formulation: a cumulative dose-response study in chronic obstructive pulmonary disease patients.
    Cuvelier A; Muir JF; Benhamou D; Weitzenblum E; Zuck P; Delacenserie R; Taytard A; Iacono P
    Respir Care; 2002 Feb; 47(2):159-66. PubMed ID: 11812272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
    Balkissoon R; Make B
    COPD; 2008 Aug; 5(4):221-7. PubMed ID: 18671147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Routine nebulized ipratropium and albuterol together are better than either alone in COPD. The COMBIVENT Inhalation Solution Study Group.
    Chest; 1997 Dec; 112(6):1514-21. PubMed ID: 9404747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
    Lindberg A; Szalai Z; Pullerits T; Radeczky E
    Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.